2023

Fletcher AA, Kelly MS, Eckhoff AM, Allen PJ. Revisiting the intrinsic mycobiome in pancreatic cancer. Nature. 2023 Aug;620(7972):E1-E6. [Pubmed]

Eckhoff AM, Brown MC, Landa K, Naqvi I, Holl EK, Boczkowski D, Fletcher A, Rhodin KE, Giang MH, Sullenger B, Beasley GM, Allen PJ, Nair SK. Functional reprogramming of peripheral blood monocytes by soluble mediators in patients with pancreatic cancer and intraductal papillary mucinous neoplasms. Front Immunol. 2023 Jul 28;14:1116034. [Pubmed]

Iyer MK, Shi C, Eckhoff AM, Fletcher A, Nussbaum DP, Allen PJ. Digital spatial profiling of intraductal papillary mucinous neoplasms: Toward a molecular framework for risk stratification. Sci Adv. 2023 Mar 15;9(11):eade4582. [Pubmed]

Eckhoff AM, Kanu E, Bao M, Blazer DG 3rd, Zani S, Lidsky ME, Allen PJ, Nussbaum DP. Survival for Patients with Radiographically Occult Metastatic Pancreatic Cancer in the Era of Modern Multiagent Chemotherapy. Ann Surg Oncol. 2023 Jun;30(6):3194-3196. [Pubmed]

Eckhoff AM, Fletcher AA, Kelly MS, Dohlman A, McIntyre CA, Shen X, Iyer MK, Nussbaum DP, Allen PJ. Comprehensive Assessment of the Intrinsic Pancreatic Microbiome. bioRxiv 2023.08.12.553074 [bioRxiv]

2022

Eckhoff AM, Fletcher AA, Landa K, Iyer M, Nussbaum DP, Shi C, Nair SK, Allen PJ. Multidimensional Immunophenotyping of Intraductal Papillary Mucinous Neoplasms Reveals Novel T Cell and Macrophage Signature. Ann Surg Oncol. 2022;29(12):7781-7788. [Pubmed]

Eckhoff A, Allen PJ. ASO Author Reflections: Spatial Immunophenotyping of Intraductal Papillary Mucinous Neoplasm. Ann Surg Oncol. 2022;29(12):7789-7790. [Pubmed]

McIntyre CA, Rodrigues C, Santharaman AV, Goldman DA, Javed AA, Ciprani D, Pang N, Lokshin A, Gonen M, Al Efishat MA, He J, Burkhart R, Burns W 3rd, Weiss M, D'Angelica MI, Kingham TP, Balachandran VP, Drebin JA, Jarnagin WR, Lillemoe KD, Brugge W, Casey B, Lennon AM, Schattner M, Wolfgang CL, Del Castillo CF, Allen PJ. Multiinstitutional Validation Study of Cyst Fluid Protein Biomarkers in Patients With Cystic Lesions of the Pancreas. Ann Surg. 2022 Aug 1;276(2):e129-e132. [Pubmed]

Nussbaum DP, Martz CA, Waters AM, Barrera A, Rutter JC, Cerda-Smith CG, Stewart AE, Wu C, Cakir M, Levandowski CB, Kantrowitz DE, McCall SJ, Pierobon M, Petricoin EF III, Smith JJ, Reddy TE, Der CJ, Taatjes DJ, Wood KC. Mediator Kinase Inhibition Impedes Transcriptional Plasticity and Prevents Resistance to ERK/MAPK-Targeted Therapy in KRAS-Mutant Cancers. bioRxiv 2022.09.17.508384. [bioRxiv]

2021

Allen PJ. Biomarker Development in IPMN: The Problem of the Known Unknowns and the Unknown Unknowns. Ann Surg. 2021 Jun 1;273(6):e276-e277. [Pubmed]

McIntyre CA, Zambirinis CP, Pulvirenti A, Chou JF, Gonen M, Balachandran VP, Kingham TP, D'Angelica MI, Brennan MF, Drebin JA, Jarnagin WR, Allen PJ. Detailed Analysis of Margin Positivity and the Site of Local Recurrence After Pancreaticoduodenectomy. Ann Surg Oncol. 2021 Jan;28(1):539-549. [Pubmed]

Allen PJ. Response to the Comment on "Intraductal Papillary Mucinous Neoplasms: Have IAP Consensus Guidelines Changed Our Approach?: Results From a Multi-institutional Study". Ann Surg. 2021 Dec 1;274(6):e706-e707. [Pubmed]

Pulvirenti A, Margonis GA, Morales-Oyarvide V, McIntyre CA, Lawrence SA, Goldman DA, Gonen M, Weiss MJ, Ferrone CR, He J, Brennan MF, Cameron JL, Lillemoe KD, Kingham TP, Balachandran V, Qadan M, D'Angelica MI, Jarnagin WR, Wolfgang CL, Castillo CF, Allen PJ. Intraductal Papillary Mucinous Neoplasms: Have IAP Consensus Guidelines Changed our Approach?: Results from a Multi-institutional Study. Ann Surg. 2021 Dec 1;274(6):e980-e987. [Pubmed]

2019

McIntyre CA, Pulvirenti A, Lawrence SA, Seier K, Gonen M, Balachandran VP, Kingham TP, DʼAngelica MI, Drebin JA, Jarnagin WR, Allen PJ. Neutrophil-to-Lymphocyte Ratio as a Predictor of Invasive Carcinoma in Patients With Intraductal Papillary Mucinous Neoplasms of the Pancreas. Pancreas. 2019 Jul;48(6):832-836. [Pubmed]

Lim J, Allen PJ. The diagnosis and management of intraductal papillary mucinous neoplasms of the pancreas: has progress been made? Updates Surg. 2019 Jun;71(2):209-216. [Pubmed]

Lawrence SA, McIntyre CA, Pulvirenti A, Seier K, Chou Y, Gonen M, Balachandran VP, Kingham TP, D'Angelica MI, Drebin JA, Jarnagin WR, Allen PJ. Perioperative Bundle to Reduce Surgical Site Infection after Pancreaticoduodenectomy: A Prospective Cohort Study. J Am Coll Surg. 2019 Apr;228(4):595-601. [Pubmed]

Kunstman JW, Goldman DA, Gönen M, Balachandran VP, D'Angelica MI, Kingham TP, Jarnagin WR, Allen PJ. Outcomes after Pancreatectomy with Routine Pasireotide Use. J Am Coll Surg. 2019 Feb;228(2):161-170.e2. [Pubmed]

Pulvirenti A, Rao D, Mcintyre CA, Gonen M, Tang LH, Klimstra DS, Fleisher M, Ramanathan LV, Reidy-Lagunes D, Allen PJ. Limited role of Chromogranin A as clinical biomarker for pancreatic neuroendocrine tumors. HPB (Oxford). 2019 May;21(5):612-618. [Pubmed]

2018

Al Efishat M, Allen PJ. ASO Author Reflections: Progression after Resection of Noninvasive or Microinvasive Intraductal Papillary Mucinous Neoplasms. Ann Surg Oncol. 2018 Dec;25(Suppl 3):822-823. [Pubmed]

McIntyre CA, Allen PJ. How Long Should Patients with Cystic Lesions of the Pancreas Be Followed? Adv Surg. 2018 Sep;52(1):223-233. [Pubmed]

Al Efishat M, Attiyeh MA, Eaton AA, Gönen M, Basturk O, Klimstra D, D'Angelica MI, DeMatteo RP, Kingham TP, Balachandran V, Jarnagin WR, Allen PJ. Progression Patterns in the Remnant Pancreas after Resection of Non-Invasive or Micro-Invasive Intraductal Papillary Mucinous Neoplasms (IPMN). Ann Surg Oncol. 2018 Jun;25(6):1752-1759. [Pubmed]

Allen PJ. The diagnosis and management of cystic lesions of the pancreas. Chin Clin Oncol. 2017 Dec;6(6):60. [Pubmed]

Pak LM, Schattner MA, Balachandran V, D'Angelica MI, DeMatteo RP, Kingham TP, Jarnagin WR, Allen PJ. The clinical utility of immunoglobulin G4 in the evaluation of autoimmune pancreatitis and pancreatic adenocarcinoma. HPB (Oxford). 2018 Feb;20(2):182-187. [Pubmed]

Al Efishat MA, Attiyeh MA, Eaton AA, Gönen M, Prosser D, Lokshin AE, Castillo CF, Lillemoe KD, Ferrone CR, Pergolini I, Mino-Kenudson M, Rezaee N, Dal Molin M, Weiss MJ, Cameron JL, Hruban RH, D'Angelica MI, Kingham TP, DeMatteo RP, Jarnagin WR, Wolfgang CL, Allen PJ. Multi-institutional Validation Study of Pancreatic Cyst Fluid Protein Analysis for Prediction of High-risk Intraductal Papillary Mucinous Neoplasms of the Pancreas. Ann Surg. 2018 Aug;268(2):340-347. [Pubmed]

Allen PJ, D'Angelica MI, Kingham TP, Balachandran VK, Jarnagin WR. Levels of Evidence in Medical Research: "Bigger Is Not Always Better". Ann Surg. 2018 May;267(5):e96-e97. [Pubmed]

Attiyeh MA, Fernández-Del Castillo C, Al Efishat M, Eaton AA, Gönen M, Batts R, Pergolini I, Rezaee N, Lillemoe KD, Ferrone CR, Mino-Kenudson M, Weiss MJ, Cameron JL, Hruban RH, D'Angelica MI, DeMatteo RP, Kingham TP, Jarnagin WR, Wolfgang CL, Allen PJ. Development and Validation of a Multi-institutional Preoperative Nomogram for Predicting Grade of Dysplasia in Intraductal Papillary Mucinous Neoplasms (IPMNs) of the Pancreas: A Report from The Pancreatic Surgery Consortium. Ann Surg. 2018 Jan;267(1):157-163. [Pubmed]

2017

Lawrence SA, Attiyeh MA, Seier K, Gönen M, Schattner M, Haviland DL, Balachandran VP, Kingham TP, D'Angelica MI, DeMatteo RP, Brennan MF, Jarnagin WR, Allen PJ. Should Patients With Cystic Lesions of the Pancreas Undergo Long-term Radiographic Surveillance?: Results of 3024 Patients Evaluated at a Single Institution. Ann Surg. 2017 Sep;266(3):536-544. [Pubmed]

Allen PJ. Current Controversy of Radiographic Surveillance of Patients With Branch-duct IPMN and Pancreatic Cysts: Commentary on: Ductal Carcinoma Arising in a Largely Unchanged Presumed Branch Duct IPMN After 10 Years of Surveillance. Ann Surg. 2017 Dec;266(6):e41. [Pubmed]

Pak LM, D'Angelica MI, DeMatteo RP, Kingham TP, Balachandran VP, Jarnagin WR, Allen PJ. Natural History of Patients Followed Radiographically with Mucinous Cysts of the Pancreas. J Gastrointest Surg. 2017 Oct;21(10):1599-1605. [Pubmed]

2016

Allen PJ, Iacobuzio-Donahue CA, Klimstra DS. Cyst Fluid Analysis in Pancreatic Intraductal Papillary Mucinous Neoplasms. Clin Cancer Res. 2016 Oct 15;22(20):4966-4967. [Pubmed]

Ma LW, Dominguez-Rosado I, Gennarelli RL, Bach PB, Gonen M, D'Angelica MI, DeMatteo RP, Kingham TP, Brennan MF, Jarnagin WR, Allen PJ. The Cost of Postoperative Pancreatic Fistula Versus the Cost of Pasireotide: Results from a Prospective Randomized Trial. Ann Surg. 2017 Jan;265(1):11-16. [Pubmed]

Allen PJ, Kuk D, Castillo CF, Basturk O, Wolfgang CL, Cameron JL, Lillemoe KD, Ferrone CR, Morales-Oyarvide V, He J, Weiss MJ, Hruban RH, Gönen M, Klimstra DS, Mino-Kenudson M. Multi-institutional Validation Study of the American Joint Commission on Cancer (8th Edition) Changes for T and N Staging in Patients With Pancreatic Adenocarcinoma. Ann Surg. 2017 Jan;265(1):185-191. [Pubmed]

Al Efishat M, Allen PJ. Therapeutic Approach to Cystic Neoplasms of the Pancreas. Surg Oncol Clin N Am. 2016 Apr;25(2):351-61. [Pubmed]

Wang SC, Parekh JR, Porembka MR, Nathan H, D'Angelica MI, DeMatteo RP, Fong Y, Kingham TP, Jarnagin WR, Allen PJ. A Pilot Study Evaluating Serum MMP7 as a Preoperative Prognostic Marker for Pancreatic Ductal Adenocarcinoma Patients. J Gastrointest Surg. 2016 May;20(5):899-904. [Pubmed]

Eaton AA, Gonen M, Karanicolas P, Jarnagin WR, D'Angelica MI, DeMatteo R, Kingham TP, Allen PJ. Health-Related Quality of Life After Pancreatectomy: Results From a Randomized Controlled Trial. Ann Surg Oncol. 2016 Jul;23(7):2137-45. [Pubmed]

Pugalenthi A, Protic M, Gonen M, Kingham TP, Angelica MI, Dematteo RP, Fong Y, Jarnagin WR, Allen PJ. Postoperative complications and overall survival after pancreaticoduodenectomy for pancreatic ductal adenocarcinoma. J Surg Oncol. 2016 Feb;113(2):188-93. [Pubmed]

Sadot E, Reidy-Lagunes DL, Tang LH, Do RK, Gonen M, D'Angelica MI, DeMatteo RP, Kingham TP, Groot Koerkamp B, Untch BR, Brennan MF, Jarnagin WR, Allen PJ. Observation versus Resection for Small Asymptomatic Pancreatic Neuroendocrine Tumors: A Matched Case-Control Study. Ann Surg Oncol. 2016 Apr;23(4):1361-70. [Pubmed]

Chandwani R, Allen PJ. Cystic Neoplasms of the Pancreas. Annu Rev Med. 2016;67:45-57. [Pubmed]

DiMaio CJ, Weis-Garcia F, Bagiella E, Tang LH, Allen PJ. Pancreatic cyst fluid concentration of high-mobility group A2 protein acts as a differential biomarker of dysplasia in intraductal papillary mucinous neoplasm. Gastrointest Endosc. 2016 Jun;83(6):1205-9. [Pubmed]

Winter JM, Jiang W, Basturk O, Mino-Kenudson M, Fong ZV, Tan WP, Lavu H, Vollmer CM, Furth EE, Haviland D, Klimstra DS, Jarnagin WR, Lillemoe KD, Yeo CJ, Fernandez-Del Castillo C, Allen PJ. Recurrence and Survival After Resection of Small Intraductal Papillary Mucinous Neoplasm-associated Carcinomas (≤20-mm Invasive Component): A Multi-institutional Analysis. Ann Surg. 2016 Apr;263(4):793-801. [Pubmed]

2015

Allen PJ. Cystic Lesions of the Pancreas: Observe or Operate. Indian J Surg. 2015 Oct;77(5):393-4. [Pubmed]

Leal JN, Kingham TP, D'Angelica MI, DeMatteo RP, Jarnagin WR, Kalin MF, Allen PJ. Intraductal Papillary Mucinous Neoplasms and the Risk of Diabetes Mellitus in Patients Undergoing Resection Versus Observation. J Gastrointest Surg. 2015 Nov;19(11):1974-81. [Pubmed]

Sadot E, Doussot A, O'Reilly EM, Lowery MA, Goodman KA, Do RK, Tang LH, Gönen M, D'Angelica MI, DeMatteo RP, Kingham TP, Jarnagin WR, Allen PJ. FOLFIRINOX Induction Therapy for Stage 3 Pancreatic Adenocarcinoma. Ann Surg Oncol. 2015 Oct;22(11):3512-21. [Pubmed]

Tan MC, Basturk O, Brannon AR, Bhanot U, Scott SN, Bouvier N, LaFemina J, Jarnagin WR, Berger MF, Klimstra D, Allen PJ. GNAS and KRAS Mutations Define Separate Progression Pathways in Intraductal Papillary Mucinous Neoplasm-Associated Carcinoma. J Am Coll Surg. 2015 May;220(5):845-854.e1. [Pubmed]

Dudeja V, Allen PJ. Premalignant cystic neoplasms of the pancreas. Semin Oncol. 2015 Feb;42(1):70-85. [Pubmed]

Sadot E, Basturk O, Klimstra DS, Gönen M, Lokshin A, Do RK, D'Angelica MI, DeMatteo RP, Kingham TP, Jarnagin WR, Allen PJ. Tumor-associated Neutrophils and Malignant Progression in Intraductal Papillary Mucinous Neoplasms: An Opportunity for Identification of High-risk Disease. Ann Surg. 2015 Dec;262(6):1102-7. [Pubmed]

Correa-Gallego C, Allen PJ. Reply to Letter: "Operative Drainage Following Pancreatic Resections: We Need More Evidence". Ann Surg. 2015 Jun;261(6):e160. [Pubmed//pubmed.ncbi.nlm.nih.gov/24424151/]

2014

Do RK, Katz SS, Gollub MJ, Li J, LaFemina J, Zabor EC, Moskowitz CS, Klimstra DS, Allen PJ. Interobserver agreement for detection of malignant features of intraductal papillary mucinous neoplasms of the pancreas on MDCT. AJR Am J Roentgenol. 2014 Nov;203(5):973-9. [Pubmed]

Allen PJ. Pasireotide for postoperative pancreatic fistula. N Engl J Med. 2014 Aug 28;371(9):875-6. [Pubmed]

OʼReilly EM, Perelshteyn A, Jarnagin WR, Schattner M, Gerdes H, Capanu M, Tang LH, LaValle J, Winston C, DeMatteo RP, DʼAngelica M, Kurtz RC, Abou-Alfa GK, Klimstra DS, Lowery MA, Brennan MF, Coit DG, Reidy DL, Kingham TP, Allen PJ. A single-arm, nonrandomized phase II trial of neoadjuvant gemcitabine and oxaliplatin in patients with resectable pancreas adenocarcinoma. Ann Surg. 2014 Jul;260(1):142-8. [Pubmed]

Allen PJ, Gönen M, Brennan MF, Bucknor AA, Robinson LM, Pappas MM, Carlucci KE, D'Angelica MI, DeMatteo RP, Kingham TP, Fong Y, Jarnagin WR. Pasireotide for postoperative pancreatic fistula. N Engl J Med. 2014 May 22;370(21):2014-22. [Pubmed]

Ammori JB, Do RK, Brennan MF, D'Angelica MI, Dematteo RP, Fong Y, Jarnagin WR, Allen PJ. Uncinate duct dilation in intraductal papillary mucinous neoplasms of the pancreas: a radiographic finding with potentially increased malignant potential. J Gastrointest Surg. 2014 May;18(5):911-6. [Pubmed]

Correa-Gallego C, Dinkelspiel HE, Sulimanoff I, Fisher S, Viñuela EF, Kingham TP, Fong Y, DeMatteo RP, D'Angelica MI, Jarnagin WR, Allen PJ. Minimally-invasive vs open pancreaticoduodenectomy: systematic review and meta-analysis. J Am Coll Surg. 2014 Jan;218(1):129-39. [Pubmed]

Allen PJ. Operative resection is currently overutilized for cystic lesions of the pancreas. J Gastrointest Surg. 2014 Jan;18(1):182-3. [Pubmed]

Untch BR, Allen PJ. Pancreatic metastasectomy: the Memorial Sloan-Kettering experience and a review of the literature. J Surg Oncol. 2014 Jan;109(1):28-30. [Pubmed]

2013

Correa-Gallego C, Do R, Lafemina J, Gonen M, D'Angelica MI, DeMatteo RP, Fong Y, Kingham TP, Brennan MF, Jarnagin WR, Allen PJ. Predicting dysplasia and invasive carcinoma in intraductal papillary mucinous neoplasms of the pancreas: development of a preoperative nomogram. Ann Surg Oncol. 2013 Dec;20(13):4348-55. [Pubmed]

Frankel TL, LaFemina J, Bamboat ZM, D'Angelica MI, DeMatteo RP, Fong Y, Kingham TP, Jarnagin WR, Allen PJ. Dysplasia at the surgical margin is associated with recurrence after resection of non-invasive intraductal papillary mucinous neoplasms. HPB (Oxford). 2013 Oct;15(10):814-21. [Pubmed]

Konstantinidis IT, Vinuela EF, Tang LH, Klimstra DS, D'Angelica MI, Dematteo RP, Kingham TP, Fong Y, Jarnagin WR, Allen PJ. Incidentally discovered pancreatic intraepithelial neoplasia: what is its clinical significance? Ann Surg Oncol. 2013 Oct;20(11):3643-7. [Pubmed]

Au JT, Craig G, Longo V, Zanzonico P, Mason M, Fong Y, Allen PJ. Gold nanoparticles provide bright long-lasting vascular contrast for CT imaging. AJR Am J Roentgenol. 2013 Jun;200(6):1347-51. [Pubmed]

LaFemina J, Chou JF, Gönen M, Rocha FG, Correa-Gallego C, Kingham TP, Fong Y, D'Angelica MI, Jarnagin WR, DeMatteo RP, Allen PJ. Hepatic arterial nodal metastases in pancreatic cancer: is this the node of importance? J Gastrointest Surg. 2013 [Pubmed]

Araujo RL, Gaujoux S, Huguet F, Gonen M, D'Angelica MI, DeMatteo RP, Fong Y, Kingham TP, Jarnagin WR, Goodman KA, Allen PJ. Does pre-operative chemoradiation for initially unresectable or borderline resectable pancreatic adenocarcinoma increase post-operative morbidity? A case-matched analysis. HPB (Oxford). 2013 Aug;15(8):574-80. [Pubmed]

Winter JM, Tang LH, Klimstra DS, Liu W, Linkov I, Brennan MF, DʼAngelica MI, DeMatteo RP, Fong Y, Jarnagin WR, Oʼreilly EM, Allen PJ. Failure patterns in resected pancreas adenocarcinoma: lack of predicted benefit to SMAD4 expression. Ann Surg. 2013 Aug;258(2):331-5. [Pubmed]

Correa-Gallego C, Brennan MF, Dʼangelica M, Fong Y, Dematteo RP, Kingham TP, Jarnagin WR, Allen PJ. Operative drainage following pancreatic resection: analysis of 1122 patients resected over 5 years at a single institution. Ann Surg. 2013 Dec;258(6):1051-8. [Pubmed]

Lafemina J, Katabi N, Klimstra D, Correa-Gallego C, Gaujoux S, Kingham TP, Dematteo RP, Fong Y, D'Angelica MI, Jarnagin WR, Do RK, Brennan MF, Allen PJ. Malignant progression in IPMN: a cohort analysis of patients initially selected for resection or observation. Ann Surg Oncol. 2013 Feb;20(2):440-7. [Pubmed]

2012

Correa-Gallego C, Brennan MF, D'Angelica MI, DeMatteo RP, Fong Y, Kingham TP, Jarnagin WR, Allen PJ. Contemporary experience with postpancreatectomy hemorrhage: results of 1,122 patients resected between 2006 and 2011. J Am Coll Surg. 2012 Nov;215(5):616-21. [Pubmed]

Allen PJ, Hawkins WG. Invited commentary. J Am Coll Surg. 2012 Sep;215(3):370-1. [Pubmed]

Winter JM, Tang LH, Klimstra DS, Brennan MF, Brody JR, Rocha FG, Jia X, Qin LX, D'Angelica MI, DeMatteo RP, Fong Y, Jarnagin WR, O'Reilly EM, Allen PJ. A novel survival-based tissue microarray of pancreatic cancer validates MUC1 and mesothelin as biomarkers. PLoS One. 2012;7(7):e40157. [Pubmed]

Lyons JM, Karkar A, Correa-Gallego CC, D'Angelica MI, DeMatteo RP, Fong Y, Kingham TP, Jarnagin WR, Brennan MF, Allen PJ. Operative procedures for unresectable pancreatic cancer: does operative bypass decrease requirements for postoperative procedures and in-hospital days? HPB (Oxford). 2012 Jul;14(7):469-75. [Pubmed]

Gaujoux S, Torres J, Olson S, Winston C, Gonen M, Brennan MF, Klimstra DS, D'Angelica M, DeMatteo R, Fong Y, House M, Jarnagin W, Kurtz RC, Allen PJ. Impact of obesity and body fat distribution on survival after pancreaticoduodenectomy for pancreatic adenocarcinoma. Ann Surg Oncol. 2012 Sep;19(9):2908-16. [Pubmed]

Bickenbach KA, Gonen M, Tang LH, O'Reilly E, Goodman K, Brennan MF, D'Angelica MI, Dematteo RP, Fong Y, Jarnagin WR, Allen PJ. Downstaging in pancreatic cancer: a matched analysis of patients resected following systemic treatment of initially locally unresectable disease. Ann Surg Oncol. 2012 May;19(5):1663-9. [Pubmed]

Gaujoux S, Tang L, Klimstra D, Gonen M, Brennan MF, D'Angelica M, DeMatteo R, Fong Y, Jarnagin W, Allen PJ. The outcome of resected cystic pancreatic endocrine neoplasms: a case-matched analysis. Surgery. 2012 Apr;151(4):518-25. [Pubmed]

2011

Allen PJ. Significance of pathologic response to preoperative therapy in pancreatic cancer: the future ain't what it used to be. Ann Surg Oncol. 2011 Dec;18(13):3533-4. [Pubmed]

Allen PJ. Operative drains after pancreatic resection--the Titanic is sinking. HPB (Oxford). 2011 Sep;13(9):595. [Pubmed]

Winter JM, Brennan MF, Tang LH, D'Angelica MI, Dematteo RP, Fong Y, Klimstra DS, Jarnagin WR, Allen PJ. Survival after resection of pancreatic adenocarcinoma: results from a single institution over three decades. Ann Surg Oncol. 2012 Jan;19(1):169-75. [Pubmed]

Gaujoux S, Brennan MF, Gonen M, D'Angelica MI, DeMatteo R, Fong Y, Schattner M, DiMaio C, Janakos M, Jarnagin WR, Allen PJ. Cystic lesions of the pancreas: changes in the presentation and management of 1,424 patients at a single institution over a 15-year time period. J Am Coll Surg. 2011 Apr;212(4):590-600. [Pubmed]

Yopp AC, Katabi N, Janakos M, Klimstra DS, D'Angelica MI, DeMatteo RP, Fong Y, Brennan MF, Jarnagin WR, Allen PJ. Invasive carcinoma arising in intraductal papillary mucinous neoplasms of the pancreas: a matched control study with conventional pancreatic ductal adenocarcinoma. Ann Surg. 2011 May;253(5):968-74. [Pubmed]

Maker AV, Katabi N, Qin LX, Klimstra DS, Schattner M, Brennan MF, Jarnagin WR, Allen PJ. Cyst fluid interleukin-1beta (IL1beta) levels predict the risk of carcinoma in intraductal papillary mucinous neoplasms of the pancreas. Clin Cancer Res. 2011 Mar 15;17(6):1502-8. [Pubmed]

Allen PJ, Chou J, Janakos M, Strong VE, Coit DG, Brennan MF. Prospective evaluation of laparoscopic celiac plexus block in patients with unresectable pancreatic adenocarcinoma. Ann Surg Oncol. 2011 Mar;18(3):636-41. [Pubmed]

Butte JM, Brennan MF, Gönen M, Tang LH, D'Angelica MI, Fong Y, Dematteo RP, Jarnagin WR, Allen PJ. Solid pseudopapillary tumors of the pancreas. Clinical features, surgical outcomes, and long-term survival in 45 consecutive patients from a single center. J Gastrointest Surg. 2011 Feb;15(2):350-7. [Pubmed]

Maker AV, Katabi N, Gonen M, DeMatteo RP, D'Angelica MI, Fong Y, Jarnagin WR, Brennan MF, Allen PJ. Pancreatic cyst fluid and serum mucin levels predict dysplasia in intraductal papillary mucinous neoplasms of the pancreas. Ann Surg Oncol. 2011 Jan;18(1):199-206. [Pubmed]

2010

Park J, Pillarisetty VG, Brennan MF, Jarnagin WR, D'Angelica MI, Dematteo RP, G Coit D, Janakos M, Allen PJ. Electronic synoptic operative reporting: assessing the reliability and completeness of synoptic reports for pancreatic resection. J Am Coll Surg. 2010 Sep;211(3):308-15. [Pubmed]

Jayaraman S, Gonen M, Brennan MF, D'Angelica MI, DeMatteo RP, Fong Y, Jarnagin WR, Allen PJ. Laparoscopic distal pancreatectomy: evolution of a technique at a single institution. J Am Coll Surg. 2010 Oct;211(4):503-9. [Pubmed]

Gaujoux S, Allen PJ. Role of staging laparoscopy in peri-pancreatic and hepatobiliary malignancy. World J Gastrointest Surg. 2010 Sep 27;2(9):283-90. [Pubmed]

Yopp AC, Allen PJ. Prognosis of invasive intraductal papillary mucinous neoplasms of the pancreas. World J Gastrointest Surg. 2010 Oct 27;2(10):359-62. [Pubmed]

Nagula S, Kennedy T, Schattner MA, Brennan MF, Gerdes H, Markowitz AJ, Tang L, Allen PJ. Evaluation of cyst fluid CEA analysis in the diagnosis of mucinous cysts of the pancreas. J Gastrointest Surg. 2010 Dec;14(12):1997-2003. [Pubmed]

Rudloff U, Bhanot U, Gerald W, Klimstra DS, Jarnagin WR, Brennan MF, Allen PJ. Biobanking of human pancreas cancer tissue: impact of ex-vivo procurement times on RNA quality. Ann Surg Oncol. 2010 Aug;17(8):2229-36. [Pubmed]

Allen PJ. The management of intraductal papillary mucinous neoplasms of the pancreas. Surg Oncol Clin N Am. 2010 Apr;19(2):297-310. [Pubmed]

Rudloff U, Maker AV, Brennan MF, Allen PJ. Randomized clinical trials in pancreatic adenocarcinoma. Surg Oncol Clin N Am. 2010 Jan;19(1):115-50. [Pubmed]

2009

Allen PJ, Qin LX, Tang L, Klimstra D, Brennan MF, Lokshin A. Pancreatic cyst fluid protein expression profiling for discriminating between serous cystadenoma and intraductal papillary mucinous neoplasm. Ann Surg. 2009 Nov;250(5):754-60. [Pubmed]

Mezhir JJ, Brennan MF, Baser RE, D'Angelica MI, Fong Y, DeMatteo RP, Jarnagin WR, Allen PJ. A matched case-control study of preoperative biliary drainage in patients with pancreatic adenocarcinoma: routine drainage is not justified. J Gastrointest Surg. 2009 Dec;13(12):2163-9. [Pubmed]

Adams RB, Allen PJ. Surgical treatment of resectable and borderline resectable pancreatic cancer: expert consensus statement by Evans et al. Ann Surg Oncol. 2009 Jul;16(7):1745-50. [Pubmed]

2008

Allen PJ, Reiner AS, Gonen M, Klimstra DK, Blumgart LH, Brennan MF, D'Angelica M, Dematteo R, Fong Y, Jarnagin WR. Extrahepatic cholangiocarcinoma: a comparison of patients with resected proximal and distal lesions. HPB (Oxford). 2008;10(5):341-6. [Pubmed]

Vin Y, Sima CS, Getrajdman GI, Brown KT, Covey A, Brennan MF, Allen PJ. Management and outcomes of postpancreatectomy fistula, leak, and abscess: results of 908 patients resected at a single institution between 2000 and 2005. J Am Coll Surg. 2008 Oct;207(4):490-8. [Pubmed]

Maithel SK, Maloney S, Winston C, Gönen M, D'Angelica MI, Dematteo RP, Jarnagin WR, Brennan MF, Allen PJ. Preoperative CA 19-9 and the yield of staging laparoscopy in patients with radiographically resectable pancreatic adenocarcinoma. Ann Surg Oncol. 2008 Dec;15(12):3512-20. [Pubmed]

House MG, Fong Y, Arnaoutakis DJ, Sharma R, Winston CB, Protic M, Gonen M, Olson SH, Kurtz RC, Brennan MF, Allen PJ. Preoperative predictors for complications after pancreaticoduodenectomy: impact of BMI and body fat distribution. J Gastrointest Surg. 2008 Feb;12(2):270-8. [Pubmed]

Ferrone CR, Brennan MF, Gonen M, Coit DG, Fong Y, Chung S, Tang L, Klimstra D, Allen PJ. Pancreatic adenocarcinoma: the actual 5-year survivors. J Gastrointest Surg. 2008 Apr;12(4):701-6. [Pubmed]

2007

Ferrone CR, Tang LH, Tomlinson J, Gonen M, Hochwald SN, Brennan MF, Klimstra DS, Allen PJ. Determining prognosis in patients with pancreatic endocrine neoplasms: can the WHO classification system be simplified? J Clin Oncol. 2007 Dec 10;25(35):5609-15. [Pubmed]

Allen PJ, Brennan MF. The management of cystic lesions of the pancreas. Adv Surg. 2007;41:211-28. [Pubmed]

Allen PJ. Pancreatic adenocarcinoma: putting a hump in survival. J Am Coll Surg. 2007 Oct;205(4 Suppl):S76-80. [Pubmed]

House MG, Gönen M, Jarnagin WR, D'Angelica M, DeMatteo RP, Fong Y, Brennan MF, Allen PJ. Prognostic significance of pathologic nodal status in patients with resected pancreatic cancer. J Gastrointest Surg. 2007 Nov;11(11):1549-55. [Pubmed]

Gold JS, Tang LH, Gönen M, Coit DG, Brennan MF, Allen PJ. Utility of a prognostic nomogram designed for gastric cancer in predicting outcome of patients with R0 resected duodenal adenocarcinoma. Ann Surg Oncol. 2007 Nov;14(11):3159-67. [Pubmed]

2006

Mansour JC, Schwartz L, Pandit-Taskar N, D'Angelica M, Fong Y, Larson SM, Brennan MF, Allen PJ. The utility of F-18 fluorodeoxyglucose whole body PET imaging for determining malignancy in cystic lesions of the pancreas. J Gastrointest Surg. 2006 Dec;10(10):1354-60. [Pubmed]

Ferrone CR, Haas B, Tang L, Coit DG, Fong Y, Brennan MF, Allen PJ. The influence of positive peritoneal cytology on survival in patients with pancreatic adenocarcinoma. J Gastrointest Surg. 2006 Dec;10(10):1347-53. [Pubmed]

Allen PJ, D'Angelica M, Gonen M, Jaques DP, Coit DG, Jarnagin WR, DeMatteo R, Fong Y, Blumgart LH, Brennan MF. A selective approach to the resection of cystic lesions of the pancreas: results from 539 consecutive patients. Ann Surg. 2006 Oct;244(4):572-82. [Pubmed]

Strong VE, Dalal KM, Malhotra VT, Cubert KH, Coit D, Fong Y, Allen PJ. Initial report of laparoscopic celiac plexus block for pain relief in patients with unresectable pancreatic cancer. J Am Coll Surg. 2006 Jul;203(1):129-31. [Pubmed]

Allen PJ, Nissan A, Picon AI, Kemeny N, Dudrick P, Ben-Porat L, Espat J, Stojadinovic A, Cohen AM, Fong Y, Paty PB. Technical complications and durability of hepatic artery infusion pumps for unresectable colorectal liver metastases: an institutional experience of 544 consecutive cases. J Am Coll Surg. 2005 Jul;201(1):57-65. [Pubmed]

2003

Allen PJ, Jaques DP, D'Angelica M, Bowne WB, Conlon KC, Brennan MF. Cystic lesions of the pancreas: selection criteria for operative and nonoperative management in 209 patients. J Gastrointest Surg. 2003 Dec;7(8):970-7. [Pubmed]

Allen PJ, Jarnagin WR. Current status of hepatic resection. Adv Surg. 2003;37:29-49. [Pubmed]

Allen PJ, Kemeny N, Jarnagin W, DeMatteo R, Blumgart L, Fong Y. Importance of response to neoadjuvant chemotherapy in patients undergoing resection of synchronous colorectal liver metastases. J Gastrointest Surg. 2003 Jan;7(1):109-117. [Pubmed]

2002

Allen PJ, Stojadinovic A, Ben-Porat L, Gonen M, Kooby D, Blumgart L, Paty P, Fong Y. The management of variant arterial anatomy during hepatic arterial infusion pump placement. Ann Surg Oncol. 2002 Nov;9(9):875-80. [Pubmed]